658 related articles for article (PubMed ID: 28960823)
1. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
[TBL] [Abstract][Full Text] [Related]
2. Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients.
Xie JY; Liu WX; Ji L; Chen Z; Gao JM; Chen W; Chen GF; Zhu Q
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2037-2053. PubMed ID: 32141573
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers - a possibility for monitoring of obstructive sleep apnea syndrome.
Slouka D; Kucera R; Gal B; Betka J; Skalova A
Neuro Endocrinol Lett; 2019 Oct; 40(2):85-92. PubMed ID: 31785215
[TBL] [Abstract][Full Text] [Related]
4. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome.
Kurt OK; Yildiz N
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):371-4. PubMed ID: 23322273
[TBL] [Abstract][Full Text] [Related]
5. Morning pentraxin3 levels reflect obstructive sleep apnea-related acute inflammation.
Kobukai Y; Koyama T; Watanabe H; Ito H
J Appl Physiol (1985); 2014 Nov; 117(10):1141-8. PubMed ID: 25237185
[TBL] [Abstract][Full Text] [Related]
6. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
Dumitrache-Rujinski S; Dinu I; Călcăianu G; Erhan I; Cocieru A; Zaharia D; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):100-2, 104-6. PubMed ID: 25241557
[TBL] [Abstract][Full Text] [Related]
8. Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.
Kanbay A; Kaya E; Buyukoglan H; Ozdogan N; Kaya MG; Oymak FS; Gulmez I; Demir R; Kokturk O
Respir Med; 2011 Apr; 105(4):637-42. PubMed ID: 21183328
[TBL] [Abstract][Full Text] [Related]
9. Gamma-glutamyl transferase activity as a predictive marker for severity of obstructive sleep apnea syndrome and concomitant hypertension.
Bozkus F; Dikmen N; Demir LS
Clin Respir J; 2018 May; 12(5):1964-1973. PubMed ID: 29330970
[TBL] [Abstract][Full Text] [Related]
10. [Association between serum lipoprotein lipase level and dyslipidemia in patients with obstructive sleep apnea syndrome].
Li J; Zhang Y; Wang J; Feng P; Chen R; Cao Y; Liu C
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):403-7. PubMed ID: 24754980
[TBL] [Abstract][Full Text] [Related]
11. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome.
Kokturk O; Ciftci TU; Mollarecep E; Ciftci B
Int Heart J; 2005 Sep; 46(5):801-9. PubMed ID: 16272771
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome.
Chung S; Yoon IY; Shin YK; Lee CH; Kim JW; Lee T; Choi DJ; Ahn HJ
Sleep; 2007 Aug; 30(8):997-1001. PubMed ID: 17702269
[TBL] [Abstract][Full Text] [Related]
13. Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome.
Archontogeorgis K; Nena E; Tsigalou C; Voulgaris A; Xanthoudaki M; Froudarakis M; Steiropoulos P
Pulm Med; 2016; 2016():8081723. PubMed ID: 27843647
[No Abstract] [Full Text] [Related]
14. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
Ye J; Liu H; Li Y; Liu X; Zhu JM
Chin Med J (Engl); 2007 Sep; 120(17):1482-6. PubMed ID: 17908454
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 level is correlated with apnea hypopnea index in patients with obstructive sleep apnea sindrome.
Mutlu LC; Tülübaş F; Alp R; Kaplan G; Yildiz ZD; Gürel A
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4161-4166. PubMed ID: 29028081
[TBL] [Abstract][Full Text] [Related]
16. Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome.
Sökücü SN; Karasulu L; Dalar L; Ozdemir C; Seyhan EC; Aydin S; Altin S
Arch Bronconeumol; 2013 Aug; 49(8):321-5. PubMed ID: 23701956
[TBL] [Abstract][Full Text] [Related]
17. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome.
Koseoglu HI; Altunkas F; Kanbay A; Doruk S; Etikan I; Demir O
J Thromb Thrombolysis; 2015 Feb; 39(2):179-85. PubMed ID: 25002338
[TBL] [Abstract][Full Text] [Related]
18. Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia?
Hira HS; Shukla A; Kaur A; Kapoor S
Ann Saudi Med; 2012; 32(1):37-42. PubMed ID: 22156638
[TBL] [Abstract][Full Text] [Related]
19. Diastolic dysfunction in men with severe obstructive sleep apnea syndrome but without cardiovascular or oxidative stress-related comorbidities.
Papanikolaou J; Ntalapascha M; Makris D; Koukoubani T; Tsolaki V; Zakynthinos G; Gourgoulianis K; Zakynthinos E
Ther Adv Respir Dis; 2019; 13():1753466619880076. PubMed ID: 31566076
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction and inflammatory reactions of elderly and middle-aged men with obstructive sleep apnea syndrome.
Chung S; Yoon IY; Shin YK; Lee CH; Kim JW; Ahn HJ
Sleep Breath; 2009 Mar; 13(1):11-7. PubMed ID: 18777130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
